- $133.23m
- $106.27m
- $23.29m
Annual income statement for Repositrak, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18 | 19.1 | 20.5 | 22.6 | 23.3 |
| Cost of Revenue | |||||
| Gross Profit | 14.9 | 15.8 | 17 | 18.9 | 20 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 13.6 | 14 | 15.4 | 16.4 | 15.4 |
| Operating Profit | 4.41 | 5.09 | 5.02 | 6.23 | 7.84 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 4.13 | 5.91 | 6.33 | 7.65 | 9.52 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4 | 5.59 | 5.96 | 6.98 | 7.57 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4 | 5.59 | 5.96 | 6.98 | 7.57 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.42 | 5 | 5.41 | 6.62 | 7.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.181 | 0.263 | 0.286 | 0.345 | 0.39 |
| Dividends per Share |